This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Pherin Pharmaceuticals, Inc.
Drug Names(s): PH15
Description: PH15 belongs to a new class of proprietary compounds called pherins. Based on the company's pipeline, PH15 is likely a vomeropherin which is proposed to modulate basal forebrain centers acting on peripheral chemosensory receptors in the nasal passages to initiate neural impulses.
Pink Sheet FDA Performance Tracker: User Fee Goal Dates
Additional information available to subscribers only: